嘌呤核苷磷酸化酶
核苷
生物催化
化学
嘧啶
胸苷磷酸化酶
组合化学
嘌呤
酶
生物化学
基质(水族馆)
合成生物学
催化作用
立体化学
核苷酸
核酸
定向分子进化
可扩展性
计算生物学
磷解
嘧啶类似物
核苷类似物
定向进化
胸苷
酶催化
蛋白质工程
生物
级联反应
作者
Gaofei Liu,Jialing Wang,Fan Yang,Yuhan Sun,Fuxue Chen,Xi Wang,Xingcheng Shao,Yanbin Lu,Bin Wu
标识
DOI:10.1021/acscatal.6c06716
摘要
Abstract 2′/3′-Functionalized nucleoside analogs are valuable therapeutic agents and essential building blocks for nucleic acid-based medicines; however, their scalable biocatalytic synthesis remains challenging due to insufficient enzyme robustness under process-relevant conditions. Here, we developed an ancestral sequence reconstruction (ASR)-guided engineering strategy integrated with kcat/Km-based virtual screening to generate a process-compatible thymidine phosphorylase (TP) variant for scalable nucleoside biosynthesis. Among the reconstructed candidates, ASR114 exhibited an optimal balance between soluble expression, catalytic efficiency, and thermostability, displaying an apparent half-life of > 386 h at 50 °C compared with 7.7 h for wild-type EcTP. Biochemical characterization demonstrated that ASR114 enhanced catalytic efficiency toward multiple 2′/3′-functionalized pyrimidine nucleoside donors, with up to a 5.4-fold improvement in kcat/Km values. Molecular dynamics simulations suggested that the enhanced catalytic performance of ASR114 was associated with reduced structural flexibility, optimized substrate interactions, and alleviated conformational strain during substrate recognition. By integrating ASR114, EcPNP, and EcADA into a multienzyme cascade system, we established a crude enzyme-based platform for the synthesis of diverse 2′/3′-functionalized purine nucleoside analogs. The optimized process was successfully scaled to 120 L, enabling kilogram-scale synthesis of eight nucleoside analogs with isolated yields of up to 80.3%. This study establishes an evolution-guided framework for engineering process-compatible biocatalysts by integrating ancestral enzyme engineering, computational prioritization, and process-oriented biocatalysis for the scalable synthesis of complex nucleoside analogs.
科研通智能强力驱动
Strongly Powered by AbleSci AI